tldrdailynews.com logo

Moderna’s COVID Vaccine Gains Full FDA Approval for Children Aged 6 Months and Older

1 min read
Source: Reuters
Moderna’s COVID Vaccine Gains Full FDA Approval for Children Aged 6 Months and Older
Photo: Reuters
TL;DR

The FDA has granted full approval for Moderna's COVID-19 vaccine, Spikevax, for children aged 6 months to 11 years at increased risk, expanding beyond emergency use authorization, with availability expected for the 2025-26 season.

Topics:businesshealth#children-6-months-and-older#covid-19-vaccine#full-approval#health#moderna#us
Share this article
  1. Moderna gets full US approval for COVID shot in at-risk children 6 months and older  Reuters
  2. FDA grants full approval to Moderna’s Covid vaccine for children but limits eligibility  STAT
  3. Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine, Spikevax, in Children Aged 6 Months Through 11 Years at Increased Risk for COVID-19 Disease  Yahoo Finance
  4. Moderna’s Covid Shot Fully Approved by FDA for Use in Children  Bloomberg
  5. Moderna stock rating reiterated at Buy by Brookline Capital Markets  Investing.com

Want the full story? Read the original reporting

Read on Reuters